Novo Holdings increases stakes on German Novo partner – adds EUR 50m investment
German Evotec has raised DKK 1.9bn (EUR 255m), out of which the EUR 50m stem from Novo Holdings, by which the latter increases its stakes in the biotech and contract research firm, which recently started its partnership with Novo Nordisk in chronic kidney diseases.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY NIELSINE NIELSEN
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.